
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring
David Reiner‐Link, Holger Stark
European Journal of Pharmacology (2019) Vol. 848, pp. 112-120
Closed Access | Times Cited: 13
David Reiner‐Link, Holger Stark
European Journal of Pharmacology (2019) Vol. 848, pp. 112-120
Closed Access | Times Cited: 13
Showing 13 citing articles:
Fluorescent ligands: Bringing light to emerging GPCR paradigms
Mark Soave, Stephen J. Briddon, Stephen J. Hill, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 5, pp. 978-991
Open Access | Times Cited: 72
Mark Soave, Stephen J. Briddon, Stephen J. Hill, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 5, pp. 978-991
Open Access | Times Cited: 72
Fluorescence Polarization-Based Bioassays: New Horizons
Olga D. Hendrickson, Nadezhda A. Taranova, Anatoly V. Zherdev, et al.
Sensors (2020) Vol. 20, Iss. 24, pp. 7132-7132
Open Access | Times Cited: 64
Olga D. Hendrickson, Nadezhda A. Taranova, Anatoly V. Zherdev, et al.
Sensors (2020) Vol. 20, Iss. 24, pp. 7132-7132
Open Access | Times Cited: 64
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis
Faik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Živković, et al.
Neuropharmacology (2021) Vol. 186, pp. 108464-108464
Open Access | Times Cited: 21
Faik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Živković, et al.
Neuropharmacology (2021) Vol. 186, pp. 108464-108464
Open Access | Times Cited: 21
Drug screening strategies using metal-based luminescent probes
Guodong Li, Wu Chun, Dik‐Lung Ma, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 139, pp. 116270-116270
Closed Access | Times Cited: 18
Guodong Li, Wu Chun, Dik‐Lung Ma, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 139, pp. 116270-116270
Closed Access | Times Cited: 18
Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening
Vikrant Kumar, Puneeth Kumar Chunchagatta Lakshman, T.K. Prasad, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23864-e23864
Open Access | Times Cited: 6
Vikrant Kumar, Puneeth Kumar Chunchagatta Lakshman, T.K. Prasad, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23864-e23864
Open Access | Times Cited: 6
Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones
Hua Yi, Mingxia Song, Qiaoyue Guo, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3408-3408
Open Access | Times Cited: 4
Hua Yi, Mingxia Song, Qiaoyue Guo, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3408-3408
Open Access | Times Cited: 4
Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H3 receptor for Prader–Willi Syndrome
David Reiner‐Link, Ludwig Seifert, Caroline Deck, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 8
David Reiner‐Link, Ludwig Seifert, Caroline Deck, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Histamine H3 receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Silvia Sgambellone, Mohammad A. Khanfar, Silvia Marri, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117454-117454
Open Access
Silvia Sgambellone, Mohammad A. Khanfar, Silvia Marri, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117454-117454
Open Access
Histamine H 3 receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies
David Reiner‐Link, Aleksandra Živković, Olivier Labeeuw, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112150-112150
Closed Access | Times Cited: 3
David Reiner‐Link, Aleksandra Živković, Olivier Labeeuw, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112150-112150
Closed Access | Times Cited: 3
Chemical Probes for Histamine Receptor Subtypes
Markus Falkenstein, Milica Elek, Holger Stark
Current topics in behavioral neurosciences (2021), pp. 29-76
Closed Access | Times Cited: 3
Markus Falkenstein, Milica Elek, Holger Stark
Current topics in behavioral neurosciences (2021), pp. 29-76
Closed Access | Times Cited: 3
Screening for New Inhibitors of Glycine Transporter 1 and 2 by Means of MS Binding Assays
Thomas Ackermann, Georg Höfner, Klaus T. Wanner
ChemMedChem (2021) Vol. 16, Iss. 19, pp. 3094-3104
Open Access | Times Cited: 2
Thomas Ackermann, Georg Höfner, Klaus T. Wanner
ChemMedChem (2021) Vol. 16, Iss. 19, pp. 3094-3104
Open Access | Times Cited: 2